Tag: Translational Genomics Research Institute

michael j demeure md1

Carcinoid Cancer Foundation Presents Symposium on Cutting-Edge Treatment

March 23, 2010

Determining Molecular Signature:  A Guide for Targeted Therapy of Neuroendocrine Tumors

Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis.  This is the cutting-edge…

READ MORE